| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Domiphen bromide+lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrocarbonate 2.2% injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lignocaine 2% injection 2ml ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lignocaine 2% injection 20ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lignocaine 5% / Hydrocortisone acetate 0.275% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine 2%/epinephrine (1:200000) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lignocaine 2% injection 5ml ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lignocaine 1% injection 2ml ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine 1%/epinephrine (1:200000) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lignocaine 1% injection 5ml ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 0.5% injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 0.5% injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 0.5% injection solution 20 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 1% injection solution 2 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 1% injection solution 5 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 1% injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 1% injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 2% injection solution 2 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 2% injection solution 5 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 2% injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 2% injection solution 20 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lignocaine hydrochloride neutral 1% injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phospha + lidocaine hydrochloride 0ns/10mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bupivacaine- and lidocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine 1%/bupivacaine 0.375% injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine 2.5%/prilocaine 2.5% periodontal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 10%/epinephrine 0.1% topical iontophoretic patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine- and neomycin- and polymyxin B-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Lidocaine hydrochloride 2% viscous topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely lidocaine hydrochloride 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional lignocaine poisoning (disorder) |
Causative agent (attribute) |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely hydrocortisone 2 milligram/1 gram and lidocaine hydrochloride 10 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone- and lidocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing lidocaine and tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine 70mg/tetracaine 70mg transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cetylpyridinium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing lidocaine and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing allantoin and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing domiphen and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing clove oil and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing cetalkonium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aminoacridine- and lidocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine 2.5% topical ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride |
Is a |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing hyaluronic acid and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing lidocaine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing lidocaine in oropharyngeal dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental poisoning by lignocaine |
Causative agent (attribute) |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine 0.5mg powder for intradermal injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to lidocaine (finding) |
Causative agent (attribute) |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adrenaline- and lidocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine hydrocarbonate (substance) |
Is a |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride |
Is modification of (attribute) |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrocarbonate (substance) |
Is modification of (attribute) |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine hydrochloride 1% conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Domiphen- and lidocaine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine 20 mg/g cutaneous cream |
Has precise active ingredient |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine 20 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
Has precise active ingredient |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lignocaine+prilocaine 2.5%/2.5% cream (substance) |
Has basis of strength substance (attribute) |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lignocaine+prilocaine 2.5%/2.5% cream (substance) |
Has precise active ingredient |
False |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine 10 mg/actuation oromucosal spray |
Has basis of strength substance (attribute) |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine 10 mg/actuation oromucosal spray |
Has precise active ingredient |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing lidocaine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing lidocaine and prilocaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing lidocaine and tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine- and methylprednisolone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine-containing product in gingival dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing lidocaine and phenylephrine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Cetylpyridinium- and lidocaine-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrocortisone- and lidocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only allantoin and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cetylpyridinium and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only bupivacaine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Aminoacridine and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chlorhexidine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Cetalkonium and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Clove oil and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Adrenaline and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Domiphen and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrocortisone and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fluorescein stain and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only lidocaine and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing only lidocaine and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine and tetracaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only lidocaine and prilocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lidocaine and zinc oxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only hyaluronic acid and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]